Details
Stereochemistry | RACEMIC |
Molecular Formula | C7H9NO3 |
Molecular Weight | 155.1513 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1OC(=O)N(CC=C)C1=O
InChI
InChIKey=XWZXRENCCHMZNF-UHFFFAOYSA-N
InChI=1S/C7H9NO3/c1-3-4-8-6(9)5(2)11-7(8)10/h3,5H,1,4H2,2H3
Molecular Formula | C7H9NO3 |
Molecular Weight | 155.1513 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Allomethadione is an anticonvulsant. It was used for the treatment of epilepsy. Allomethadione appears to have the advantage over tridione (another anticonvulsant) in not producing ataxia or gastric irritation. Photophobia is common in patients taking tridione but allomethadione did not produce photophobia. The drug causes renal damage. The compound has been marketed in Europe.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13045529
0.3 g five times a day
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:10:36 GMT 2023
by
admin
on
Fri Dec 15 16:10:36 GMT 2023
|
Record UNII |
BFT641Z2YT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
208-389-0
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
m19
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB05337MIG
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
993
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
100000087437
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
526-35-2
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL93070
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
10683
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
DTXSID90862119
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
BFT641Z2YT
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
3666
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY | |||
|
C80254
Created by
admin on Fri Dec 15 16:10:36 GMT 2023 , Edited by admin on Fri Dec 15 16:10:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |